Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics
The central nervous system (CNS) encompasses the brain and spinal cord and is
considered the processing center and the most vital part of human body. The central …
considered the processing center and the most vital part of human body. The central …
SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers
ME Morris, V Rodriguez-Cruz, MA Felmlee - The AAPS journal, 2017 - Springer
The blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB) separate
the brain and cerebrospinal fluid (CSF) from the systemic circulation and represent a barrier …
the brain and cerebrospinal fluid (CSF) from the systemic circulation and represent a barrier …
SARS-CoV-2: is there neuroinvasion?
C McQuaid, M Brady, R Deane - Fluids and Barriers of the CNS, 2021 - Springer
Abstract Background SARS-CoV-2, a coronavirus (CoV), is known to cause acute respiratory
distress syndrome, and a number of non-respiratory complications, particularly in older male …
distress syndrome, and a number of non-respiratory complications, particularly in older male …
Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
Y Zhao, CY Zeng, XH Li, TT Yang, X Kuang, JR Du - Aging Cell, 2020 - Wiley Online Library
Alzheimer's disease (AD) is the most prevalent type of dementia, characterized by the
presence of amyloid‐β (Aβ) plaques. We previously reported that Klotho lowered Aβ levels …
presence of amyloid‐β (Aβ) plaques. We previously reported that Klotho lowered Aβ levels …
SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier
C Stüdle, H Nishihara, S Wischnewski… - Fluids and Barriers of …, 2023 - Springer
Background As a consequence of SARS-CoV-2 infection various neurocognitive and
neuropsychiatric symptoms can appear, which may persist for several months post infection …
neuropsychiatric symptoms can appear, which may persist for several months post infection …
Zika virus infects pericytes in the choroid plexus and enters the central nervous system through the blood-cerebrospinal fluid barrier
Zika virus (ZIKV) can infect and cause microcephaly and Zika-associated neurological
complications in the developing fetal and adult brains. In terms of pathogenesis, a critical …
complications in the developing fetal and adult brains. In terms of pathogenesis, a critical …
Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro
H Nishihara, S Soldati, A Mossu, M Rosito… - Fluids and Barriers of …, 2020 - Springer
Background The brain barriers establish compartments in the central nervous system (CNS)
that significantly differ in their communication with the peripheral immune system. In this …
that significantly differ in their communication with the peripheral immune system. In this …
The choroid plexus is permissive for a preactivated antigen-experienced memory B-cell subset in multiple sclerosis
The role of B cells in multiple sclerosis (MS) is increasingly recognized. B cells undergo
compartmentalized redistribution in blood and cerebrospinal fluid (CSF) during active MS …
compartmentalized redistribution in blood and cerebrospinal fluid (CSF) during active MS …
Folate receptor α-modified nanoparticles for targeting of the central nervous system
N Kuplennik, K Lang, R Steinfeld… - ACS applied materials & …, 2019 - ACS Publications
Effective and timely delivery of therapeutic agents from the systemic circulation to the central
nervous system (CNS) is often precluded by the blood–brain barrier (BBB) and the blood …
nervous system (CNS) is often precluded by the blood–brain barrier (BBB) and the blood …
In vitro models of the blood–cerebrospinal fluid barrier and their applications in the development and research of (Neuro) Pharmaceuticals
F Dabbagh, H Schroten, C Schwerk - Pharmaceutics, 2022 - mdpi.com
The pharmaceutical research sector has been facing the challenge of neurotherapeutics
development and its inherited high-risk and high-failure-rate nature for decades. This hurdle …
development and its inherited high-risk and high-failure-rate nature for decades. This hurdle …